Welcome to the website of DSM Sinochem Pharmaceuticals!

DSM Sinochem Pharmaceuticals (DSP) is the global leader in sustainable antibiotics, next generation statins and anti-fungals.

We develop, produce and sell raw materials, intermediates, active pharmaceutical ingredients (API) and drug products (DP).

Our employees worldwide work together to deliver cutting edge generics solutions that help to keep customers ahead of the

Headquartered in Singapore, the group has operations in China, India, Egypt, the Netherlands, Spain, the US and Mexico.


On September 21, DSM Sinochem Pharmaceuticals (DSP), one of the world’s leading global generic antibiotics manufacturers, will take part in the United Nations General Assembly (UNGA) High-Level Meeting on Antimicrobial Resistance (AMR) in New York. Ahead of the meeting, DSP and 12 other leading pharmaceutical companies presented a comprehensive roadmap laying out joint commitments to combat the threat of AMR. At the UNGA, Karl Rotthier, CEO of DSP, will address the Center for Disease Dynamics, Economics & Policy on AMR. He will argue that, now that the environmental impact of antibiotics manufacturing is firmly on the agenda of leading pharmaceutical companies, the industry can and should act quickly. Readmore

DSP supports fight against superbugs and welcomes the recommendations of the AMR Review.

DSM Sinochem Pharmaceuticals (DSP) welcomes the final report of Lord O’Neill’s global AMR Review, which lists concrete interventions to fight antimicrobial resistance (AMR) and the drug resistant superbugs it creates. DSP fully supports these measures. Guided by its brand promise “Quality. Reliability. Sustainability.”, DSP has been advocating for more transparency in the value chain and to stop irresponsible production of antibiotics. In line with the AMR Review recommendations, DSP is promoting the use of the best and cleanest available technology, dedicated waste water treatment plants and antimicrobial activity testing, to ensure clean and high quality production. Readmore

DSP publishes Sustainability Report 2014.


DSM Sinochem Pharmaceuticals (DSP) issues the 2014 Sustainability Report, inspired by the GRI framework. The Report gives an overview of DSP's business and sustainability performance and DSP's efforts on Sustainable Antibiotics. 

Karl Rotthier, CEO of DSP, highlighted the importance of antibiotics for mankind and our responsibility to ensure that these life-saving drugs remain effective and are thus produced responsibly. Readmore